Allena Pharmaceuticals
ALNA
ALNA was delisted on the 7th of September, 2022.
36 hedge funds and large institutions have $18M invested in Allena Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 4 reducing their positions, and 3 closing their positions.
275% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 4
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
24% more funds holding
Funds holding: 29 → 36 (+7)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
36% less capital invested
Capital invested by funds: $28.1M → $18M (-$10.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
+$1.05M |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$231K |
| 3 |
State Street
Boston,
Massachusetts
|
+$167K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$150K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$81.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.9M |
| 2 |
Renaissance Technologies
New York
|
-$556K |
| 3 |
Millennium Management
New York
|
-$244K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$113K |
| 5 |
Bank of New York Mellon
New York
|
-$44K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $34K | +$34.5K | +35,186 | +1,407% |
|
|
GG
27
Golden Green
Seneca,
South Carolina
| $30K | +$11.7K | +12,000 | +57% |
|
28
LPL Financial
San Diego,
California
| $28K | +$5.38K | +5,500 | +22% |
|
29
Osaic Holdings
Scottsdale,
Arizona
| $21K | – | – | – |
|
|
XT
30
XTX Topco
George Town,
Cayman Islands
| $19K | +$21K | +21,443 | New |
|
31
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $13K | +$14K | +14,339 | New |
|
32
Victory Capital Management
San Antonio,
Texas
| $10K | +$10.8K | +11,060 | New |
|
33
Bank of America
Charlotte,
North Carolina
| $5K | -$18 | -18 | -0.3% |
|
|
HI
34
Harbour Investments
Madison,
Wisconsin
| $5K | +$490 | +500 | +9% |
|
|
TRCT
35
Tower Research Capital (TRC)
New York
| $5K | +$1.23K | +1,254 | +32% |
|
36
Wells Fargo
San Francisco,
California
| $1K | +$164 | +167 | +13% |
|
|
37
Point72 Asset Management
Stamford,
Connecticut
| – | -$3.9M | -3,000,000 | Closed |
|
|
38
Millennium Management
New York
| – | -$244K | -187,431 | Closed |
|
|
39
Bank of New York Mellon
New York
| – | -$44K | -34,026 | Closed |
|
ALNA Hedge Fund Activity: Q3 2021 in Review
36 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Allena Pharmaceuticals (ALNA) for Q3 2021, worth a combined $18M — down 36% from $28.1M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ALNA positions and 3 closed out — a net gain of 7 holders — while 15 added to existing stakes and 4 trimmed.
The largest buyer was Altium Capital Management, opening a new position worth an estimated $1.05M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $3.9M sold.
- 36 institutional investors held Allena Pharmaceuticals (ALNA) as of Q3 2021, up from 29 in Q2 2021.
- Funds reported $18M of Allena Pharmaceuticals stock for Q3 2021, down 36% quarter-over-quarter.
- 10 funds opened new Allena Pharmaceuticals positions in Q3 2021 and 3 closed out, a net change of +7 holders.
- The largest Allena Pharmaceuticals buyer in Q3 2021 was Altium Capital Management, an estimated $1.05M added.
- The largest Allena Pharmaceuticals seller in Q3 2021 was Point72 Asset Management, an estimated $3.9M sold.
Based on aggregated 13F filings for Q3 2021.